GLP-3 (RETA) 10MG

Product Overview

Discover GLP-3 (RETA), a cutting-edge triple agonist peptide designed for advanced scientific research. Targeting GLP-1, GIP, and glucagon receptors, GLP-3 (RETA) is a powerful tool for studying metabolic regulation, weight management, and glycemic control. Ideal for researchers exploring innovative solutions for obesity, type 2 diabetes, and metabolic disorders, this peptide offers unparalleled potential in controlled laboratory settings.

Key Features

• Triple Agonist Action: Activates GLP-1, GIP, and glucagon receptors for comprehensive metabolic effects.
• High Purity: Each batch is rigorously tested for purity and sterility, ensuring reliable research outcomes.
• Lyophilized Powder: Provided in a sealed, sterile vial for easy reconstitution and storage.
• Research-Grade: Formulated specifically for in-vitro and pre-clinical studies. This product is sold strictly for scientific research purposes only.

Research Applications

GLP-3 (RETA) is a novel peptide under investigation for its potential in:

• Weight Loss Research Studies: Promotes significant fat reduction by enhancing energy expenditure and appetite suppression.
• Type 2 Diabetes Research: Improves insulin sensitivity and glycemic control in metabolic models.
• Metabolic Health Research: Explores lipid metabolism, liver function, and cardiovascular benefits in non-human subjects.
• Obesity Management Research: Outperforms dual agonists like Tirz in clinical trial simulations for fat loss.

Product Specifications

• Form: Lyophilized powder in a sterile vial
• Molecular Weight: Approximately 4,800 Da
• CAS Number: 2381089-83-2
• Available Sizes: 10mg, 30mg
• Storage: Store at -20°C, protected from light and moisture

Disclaimer

This product is sold strictly for scientific research purposes only. It is not intended for therapeutic use, diagnostic use, treatment, or prevention of any disease. Handle only by licensed professionals with appropriate equipment and facilities.